[No authors listed]
The immune checkpoint protein B7âH4 plays an important role in the positive as well as the negative regulation of immune Tâcell responses. When expressed on cancer cells, B7âH4 inhibits Tâcell activity, and numerous types of cancer cells use upregulation of B7âH4 as a survival strategy. Thus, B7âH4 is a potential target for anticancer drug therapy. Unfortunately, the cell biology of this molecule has yet to be fully elucidated. Even basic properties, such as the nature of B7âH4 interactors, are controversial. In particular, the cisâinteractors of B7âH4 on cancer cell plasma membranes have not been investigated to date. The present study used a proteomic proximityâlabelling assay to investigate the molecular neighbours of B7âH4 on the surface of the human breast cancer cells SKâBRâ3. By comparison to a comprehensive proteome analysis of SKâBRâ3 cells, the proximity method detected a relatively small number of low abundance plasma membrane proteins highly enriched for proteins known to modulate cell adhesion and immune recognition. It may be inferred that these molecules contribute to the immunosuppressive behaviour that is characteristic of B7âH4 on cancer cells.
KEYWORDS: {{ getKeywords(articleDetailText.words) }}
Sample name | Organism | Experiment title | Sample type | Library instrument | Attributes | |||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
{{attr}} | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
{{ dataList.sampleTitle }} | {{ dataList.organism }} | {{ dataList.expermentTitle }} | {{ dataList.sampleType }} | {{ dataList.libraryInstrument }} | {{ showAttributeName(index,attr,dataList.attributes) }} |
{{ list.authorName }} {{ list.authorName }} |